Weekly Medical Affairs Research Releases
STUDY BACKGROUND AND SUMMARY:
The Medical Affairs function plays a critical role in meeting current challenges in clinical development, market education, and regulatory compliance. Indeed, most health care professionals agree that Medical Affairs function takes enormous role in guiding the health care sector’s ongoing transition from simply drug marketing to dealing with a wide range of stakeholders who influence market access. As the importance of Medical Affairs continues to grow and the marketplace evolves, understanding how companies are changing Medical Affairs’ structure, staffing and investment can help leaders in both mature and emerging markets create high-impact organizations that drive results.
Best Practices, LLC created The 2013-2014 Medical Affairs Consortium to provide benchmarking and best practices across critical Medical Affairs functions including: Medical Information/ Communication, Scientific/ Medical Liaisons, Thought Leader Services, Health Outcomes & Data Management and Medical Education. Our goal is to identify the gaps in specific performance and growth prospects, as well as provide your company with pathways to success in the medical affairs function.
Section 1: Study Background –- Reviews the study background, the research approach, methodology, participant demographics, the benchmark class and key findings.
Section 2: Topical chapters -- Outlines valuable insights and findings from the study that illustrates how leading Life Sciences companies structure and organize their Medical Affairs functions in both mature and emerging markets. The research also contains current metrics around Medical Affairs staffing and investment. A separate chapter is devoted to understanding current approaches to measuring the performance of the Medical Affairs function.
About the Benchmark Class–- This study engaged 40 executives from 32 leading healthcare companies. Segmentation analysis was key to examining trends and effective practices. 23 participants make up the Mature Markets Segment, while the Emerging Markets Segment consists of 8 participants from Brazil, India and other Asia markets. The Medical Device Segment consists of 9 participants. This report includes Mature and Emerging Markets segments’ analysis and comparisons with previous benchmarking research performed in 2012.